Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 3/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 16/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4350728 | 0.96 | PDE4B (0.42) | PDE4BCHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL4190920 | 0.95 | CHRM3 (0.49) | PDE4BCHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL4098861 | 0.95 | PDE4B (0.44) | PDE4BCHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL4346720 | 0.94 | PDE4B (0.41) | PDE4BCHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL4106585 | 0.94 | CHRM3 (0.46) | PDE4BCHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL4355753 | 0.94 | PDE4B (0.41) | PDE4BCHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL4190753 | 0.94 | PDE4B (0.48) | PDE4BCHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL3430634 | 0.93 | CHRM3 (0.45) | PDE4BCHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL3425551 | 0.92 | PDE4B (0.42) | PDE4BCHRM3 | |
| SCHEMBL4349671 | 0.92 | PDE4B (0.40) | PDE4BCHRM3CHRM2CHRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2249830-A1 | DUAL PHARMACOPHORES - PDE4-MUSCARINIC ANTAGONISTICS | Glaxo Group Limited (GB) | 2010-11-17 | — | — | EP | disclosed |
| WO-2009100170-A1 | DUAL PHARMACOPHORES - PDE4-MUSCARINIC ANTAGONISTICS | GLAXO GROUP LIMITED (GB) | 2009-08-13 | — | — | WO | disclosed |